Unlikely Model for H.I.V. Prevention: Adult Film Industry

Stephanie Diani for The New York Times

INDUSTRY DATABASE Shylar Cobi, right, a film producer, confirmed test results of the actors who perform as James Deen and Stoya.

LOS ANGELES — Before they take off all their clothes, the actors who perform as James Deen and Stoya go through a ritual unique to the heterosexual adult film industry.

First, they show each other their cellphones: Each has an e-mail from a laboratory saying he or she just tested negative for H.I.V., syphilis, chlamydia and gonorrhea.

Then they sit beside the film’s producer, Shylar Cobi, as he checks an industry database with their real names to confirm that those negative tests are less than 15 days old.

Then, out on the pool terrace of the day’s set — a music producer’s hilltop home with a view of the Hollywood sign — they yank down their pants and stand around joking as Mr. Cobi quickly inspects their mouths, hands and genitals for sores.

“I’m not a doctor,” Mr. Cobi, who wears a pleasantly sheepish grin, says. “I’m only qualified to do this because I’ve been shooting porn since 1990 and I know what looks bad.”

Bizarre as the ritual is, it seems to work.

The industry’s medical consultants say that about 350,000 sex scenes have been shot without condoms since 2004, and H.I.V. has not been transmitted on a set once.

Outside the world of pornography, the industry’s testing regimen is not well known, and no serious academic study of it has ever been done. But when it was described to several AIDS experts, they all reacted by saying that there were far fewer infections than they would have expected, given how much high-risk sex takes place.

“I don’t think there’s any question that it works,” said Dr. Allan Ronald, a Canadian AIDS specialist who did landmark studies of the virus in prostitutes in a Nairobi slum. “I’m a little uncomfortable, because it’s giving the wrong message — that you can have multiple sex partners without condoms — but I can’t say it doesn’t work.”

Despite the regimen’s apparent success, California health officials and an advocacy group, the AIDS Healthcare Foundation, are trying to make it illegal to shoot without condoms. They argue that other sexually transmitted diseases are rampant in the industry, though the industry trade group disputes that.

In January, the city of Los Angeles passed a law requiring actors to wear condoms. A measure to do the same for the whole county is on the ballot on Tuesday.

Producers say the condom requirement will drive them out of business since consumers will not buy such films. Local newspapers like The Los Angeles Times oppose the ballot measure, calling it well-intentioned but unenforceable, and warning that it could drive up to 10,000 jobs out of state.

Very frequent testing makes it almost impossible for an actor to stay infected without being caught, said Dr. Jacques Pepin, the author of “The Origins of AIDS” and an expert on transmission rates. “And if you are having sex mostly with people who themselves are tested all the time, this must further reduce the risk.”

When the virus first enters a high-risk group like heroin users, urban prostitutes or habitués of gay bathhouses, it usually infects 30 to 60 percent of the cohort within a few years, studies have shown. The same would be expected in pornography, where performers can have more than a dozen partners a month, but the industry says self-policing has prevented it.

“Our talent base has sex exponentially more than other people, but we’re all on the same page about keeping it out,” said Steven Hirsch, the founder of Vivid Entertainment, one of the biggest studios.

Performers have to test negative every 28 days, although some studios recently switched to every 14.

If a test is positive, all the studios across the country that adhere to standards set by the Free Speech Coalition, an industry trade group, are obliged to stop filming until all the on-screen partners of that performer, all their partners, and all their partners’ partners, are found and retested. In 2004, the industry shut down for three months to do that.

It has had briefer shutdowns in each of the last four years.

In 2009 and 2010, no other infected performers were found. Coalition representatives said an infected woman in 2009, from Nevada, may have had an infected boyfriend, and offered evidence that a man infected in 2010 in Florida had worked outside the industry as a prostitute. The 2011 test was a false positive.

A shutdown in August came after several actors got syphilis, not H.I.V. All performers were given a choice: Take antibiotics, or pass two back-to-back syphilis tests 14 days apart.

Read More..

DealBook Column: The Election Won't Solve All Puzzles

Here comes more uncertainty.

It may sound counterintuitive, but whatever the outcome of the election — whether President Obama or Mitt Romney wins — the economy and markets are likely to face more uncertainty, not less, over the coming year.

“Uncertainty” has become the watchword over the last several years for many chief executives, politicians and economists as an explanation — or perhaps an excuse — for the economy’s slow growth, for the lack of hiring by business and for the volatility in the stock market.

“The claim is that businesses and households are uncertain about future taxes, spending levels, regulations, health care reform and interest rates. In turn, this uncertainty leads them to postpone spending on investment and consumption goods and to slow hiring, impeding the recovery,” a group of professors from Stanford University and the University of Chicago wrote in a study that found “current levels of economic policy uncertainty are at extremely elevated levels compared to recent history.” (The professors have created a Web site, policyuncertainty.com, where you can track the “uncertainty” levels.)

Come Wednesday morning, we should know who our president will be. But the uncertainty hardly ends there.

Almost immediately after the elections, the next big talking point on Wall Street and in Washington is going to be the now infamous “fiscal cliff,” a series of automatic tax increases and spending cuts that was the result of a Congressional compromise reached last summer and is to take effect on Jan. 1, unless Congress finds an alternative. Some economists say the tax increases and spending cuts in the existing agreement could shave as much as 4 percent off G.D.P. if they are not renegotiated. Already, executives say that the uncertainty over the outcome of the fiscal cliff is causing them to hold back from making new investments.

But the greatest likelihood is that the fiscal cliff isn’t going to be resolved soon at all —the betting line of the political cognoscenti is that no matter who wins, Congress will find a way to kick the issue down the road, perhaps as far as the fall of 2013, providing a new cloud of uncertainty over the economy.

For investors, the fiscal cliff includes a tax increase on dividends (making them the equivalent of ordinary income, on which rates could rise to as high as 39.6 percent) and capital gains (up to 20 percent from 15 percent). In a note to clients sent out on Sunday night, Goldman Sachs said that it expected the rate for both dividends and capital gains to be negotiated to 20 percent in either a second Obama term or a Romney presidency. But more important, Goldman noted that when similar tax increases were on the table in 1970 and 1986, “the S.& P. 500 posted negative returns in the December prior to implementation as investors locked in the lower rate.” December, the report said, “has the second-highest average monthly return” since 1928.

Many investors have already begun selling stocks and companies in anticipation of tax increases. Speculation was rampant last week that one of the reasons for the timing of the sale of George Lucas’s company, Lucasfilm, to Disney for $4.1 billion in cash and stock, was the impending changes in tax policy. (Mr. Lucas has said that he plans to donate a majority of his wealth to charity.)

Once we get past the fiscal cliff, if we do at all, there is Europe. Remember Europe? The issues in Greece and Spain have managed to stay off the front pages during the election run-up, but they have not gone away. Some economists have argued that things have gotten worse. Angela Merkel, the chancellor of Germany, who will face election in 2013, said on Monday that the fiscal crisis in Europe was likely to last at least five years. “Whoever thinks this can be fixed in one or two years is wrong,” she said.

And don’t forget the Middle East. That “uncertainty” for the world — and the global economy — isn’t going away anytime soon either. Questions about a possible attack on Iran will persist under either candidate.

And finally, there is Ben Bernanke, chairman of the Federal Reserve, one of the biggest uncertainties of them all. As I reported in this column two weeks ago, the greatest likelihood is that Mr. Bernanke will step down at the end of his term in early 2014 no matter who wins the election.

It’s possible — though unlikely — that his departure could happen even sooner if Mr. Romney wins. Over the next year and a half, Mr. Bernanke’s future as the Fed chairman will feed a sense of uncertainty among investors who have become accustomed to his easy money policies. If President Obama wins, he is likely to appoint a successor to Mr. Bernanke who is dovish on monetary policy, and more likely to keep printing money as Mr. Bernanke has, a strategy that comes with its own risks. If Mr. Romney wins, he may appoint a more hawkish chairman, a move that could create a different sense of uncertainty about how the Federal Reserve will unwind itself from Mr. Bernanke’s policies.

None of these issues are new. President Obama took office facing a fiscal policy dispute that was not and probably could not be settled given the gridlock in Congress. No solution is in sight for Europe’s problems. Tension in the Middle East is escalating as fast as nuclear technology. And the Federal Reserve’s monetary policy is at its most opaque since the Reagan administration.

All of which shows that the comedian Jon Stewart is more on target than ever with the cheeky title of his election coverage on “The Daily Show” on Comedy Central. Carrying on a tradition, it is known as “Indecision 2012.”

Update that to 2013, and it’s good for another year.

Read More..

State Supreme Court wants Arizona donors audited

SACRAMENTO — An Arizona group was scrambling late Sunday to keep secret the individuals behind its $11-million donation to a California campaign fund after California's Supreme Court, in a rare and dramatic weekend action, ordered it to turn over records that could identify the donors.

The order followed days of frenzied legal battles between California regulators, who have tried to get documents related to the anonymous contribution before election day, and attorneys for the Arizona nonprofit who have resisted delivering them.

The showdown continued into the night Sunday, with no records produced nearly seven hours after the justices' late-afternoon deadline. Lawyers for the nonprofit said they were trying to comply even as they rushed to ask the U.S. Supreme Court to halt to the audit.

The $11 million went to a committee that is fighting tax increases proposed by Gov. Jerry Brown in Proposition 30 and promoting an initiative that could limit political spending by unions, Proposition 32. The donation has been among the most controversial moves of this election season, with Brown railing against the "shadowy" contributors at campaign appearances.

The case, which has the potential to reshape a growing sector of political giving, has put California at the forefront of a national debate over concealed political donations. Ann Ravel, chairwoman of the state Fair Political Practices Commission, which initially sued the Arizona group, called the California high court's decision historic.

It all began with a complaint from activists at Common Cause, who said the $11-million donation from Americans for Responsible Leadership violated a new California regulation. Federal law allows nonprofits to keep the identities of their donors confidential, but a rule implemented here in May says contributors must be identified if they give to nonprofits with the intention of spending money on state campaigns.

The matter has rocketed from court to court as Ravel's commission fought to obtain the Arizona group's records. The seven justices of the state Supreme Court, based in San Francisco, made the unusual decision to consider the matter over the weekend. On Sunday afternoon, they held a conference call to discuss it.

Shortly after 3 p.m., they ordered Americans for Responsible Leadership to produce — in less than an hour — the records sought by Ravel, a Brown appointee. The justices did not explain their unanimous decision, indicating in their order that they would consider the legal issues in a later, more detailed ruling.

But no records were delivered as a team of auditors and lawyers waited in the commission's Sacramento office, prepared to dig into the nonprofit's emails, text messages, financial statements and meeting minutes. Their task would be to comb the disclosures for any sign that the contribution violated the new California regulation.

If the Arizona group was found to be in violation, the state planned to direct the nonprofit to disclose the donor names and was ready to back up the directive by seeking another court order, if needed, Ravel said.

Lawyers for Americans for Responsible Leadership balked at the California court's order, preferring to ask the U.S. Supreme Court to weigh in on the case before turning over anything. In the early evening, they asked the California jurists for more time — at least until 9 a.m. Monday — to comply.

That would provide enough time, they said, to request an emergency stay from the nation's high court. Attorneys defending the nonprofit group wrote to Washington outlining their case.

"Disclosure in this highly charged political environment and in the face of an unprecedented and vehemently legally contested investigation is impermissible viewpoint discrimination and plainly violative of ARL's First Amendment rights," Thad Davis, a lawyer for the nonprofit, said in his letter to the U.S. Supreme Court.

Justice Anthony Kennedy has authority over Western states and can issue a stay in this case.

Meanwhile, the state court told the Arizona group there would be no extension.

At risk of being in contempt of the state court, lawyers for the nonprofit said they would begin an "attempt to comply with the order."

"While we are working to deliver the records, we still believe the FPPC does not have the authority to take such an action," said Matt Ross, a spokesman for the group's legal team, in a statement Sunday night.

Ravel said she had staff members prepared to work all night to review whatever the Arizona group produced.

A career government lawyer, Ravel is hardly known in Sacramento as a firebrand. But the Arizona group says in its court filings that she is conducting a "one-woman media onslaught, rabblerousing and prejudging, including 'tweeting' her incendiary view."

State authorities are keeping the pressure on as election day looms.

California Atty. Gen. Kamala Harris, whose office is helping to represent the Fair Political Practices Commission in court, said in an interview that the Arizona group's legal maneuvers are "an effort to obstruct the process and run out the clock."

chris.megerian@latimes.com

maura.dolan@latimes.com

Times staff writer Evan Halper contributed to this report.

Read More..

Have Your Say: TenderTree Can Help You Pick a Caregiver

At this point practically every restaurant, shop, or handyman service has a Yelp, Google, or Angie’s List review to help us decide who gets our money. But when it comes to a far more important and subtle kind of decision, finding the right person to take care of an elderly or disabled friend or relative, the internet offers very little guidance.

Startup TenderTree is hoping to be that guide. A Summer graduate of incubator 500 Startups, TenderTree is doing the same for hiring a home care provider that UrbanSitter has done for finding a babysitter – helping people find and hire a qualified worker online and at a lower cost.

When someone needs to hire a caregiver, it’s typical to go through a government or non-profit agency. The problem, says TenderTree founder Andy Argawal, is that you rarely have a say about who comes into your home. You can always send back a care provider that you don’t think is a good fit, but you don’t get the chance to check someone out before they walk in the front door. TenderTree, Argawal says, is different because it lets customers pick out and hire professional caregivers based on their qualifications and personalities.

For Jim Cadena, a customer who used TenderTree to find assistance for his 92-year-old mother, the ability to pick out and personally interview who he hired was the best feature of the service. “Agencies are daunting, and they just send you people without you getting a choice,” he says. Cadena says the process of finding someone was as simple as posting the job description on TenderTree, sifting through responses, and interviewing a few candidates. The level of quality of the caregivers was much higher than what he experienced with agency workers, and the price was far lower, he added.

On average most agencies charge between $15 and $30 per hour for caregiver services, according to a recent study. (Cadena says he’s paid $28 per hour). Agency-hired workers only take home about half of those wages, says Robert Woods, a home-care provider who used to work for an agency and now gets jobs through TenderTree. On the platform, providers set their own rate and the company takes a small cut of their earnings. Though Argawal wouldn’t disclose the exact percentage TenderTree takes, he says much of it goes toward insuring each caregiver with a $3 million policy – it’s clearly a volume play for the startup. TenderTree is looking to create as large a marketplace as possible for caregivers and those in need of their help, and take its small piece of the action.

TenderTree also handles all the payroll tax paperwork and deducts payments from a customer’s credit card at the end of each week. Workers log their hours on the platform, and the customer approves them for payment.

Before offering them up for hire, TenderTree does extensive criminal background checks and skills verifications on every person accepted into the program. Unlike a pet sitter or babysitter, caregivers often need to have specific training and certifications to handle a patient’s medical needs.

The types of care providers available on TenderTree range from companions who cook, clean and provide conversation, to certified aides who can assist the elderly and disabled with feeding and bathing. At the most skilled end of the spectrum are licensed nurses who provide in-home medical care. There’s also speech and occupational therapists available for hire that can assist with developmental and physical disabilities.

TenderTree launched its private beta in March 2012, and has had “thousands” of customers and caregivers sign up. Currently the service is available for customers in the San Francisco Bay Area that pay out of pocket for home care, not those paying with insurance plans or government aid. That is the biggest barrier to the startup’s plans to scale broadly. If it really has the goal of helping the largest number of people – both patients and caregivers – it will need to find a way to accept the forms of payment that most people use.

Read More..

Bac Films shops Gael Garcia Bernal starrer to AFM buyers

LOS ANGELES (TheWrap.com) – Bac Films International has picked up sales duties on “The Ardor,” an Amazon-set feature from director, Pablo Fendrik.

Gael Garcia Bernal, left, and Alice Braga will star in this modern day Western, which is being sold at this week’s American Film Market.

Bernal will play an Amazon shaman who seeks revenge in the jungle after witnessing an attack. The film is due to start filming in March. Bac‘s AFM slate also includes Baltasar Kormakur‘s real life survival tale “The Deep,” which is Iceland’s entry for the 2013 foreign film Oscars.

Other films that Bac is handling at the AFM include “Hidden Diary” with Catherine Deneuve.

The film tells the story of an independent and single woman who lives in Canada. She is pregnant. Her parents still live in France in the small town she grew up. But while visiting them for holidays, she discovers her grand-mother’s hidden story, a woman who gave up her home and family in the fifties and never came back. Audrey will try to know more about it and this investigation will force her own mother to reveal a secret deeply buried.

Movies News Headlines – Yahoo! News

Read More..

Chelation Therapy Shows Slight Benefit in Heart Disease Clinical Trial

LOS ANGELES — To the surprise of many cardiologists, a controversial alternative therapy proved beneficial to people with heart disease, reducing the rate of death and cardiovascular problems in a clinical trial, researchers said on Sunday.

The benefit of the treatment, known as chelation therapy, barely reached statistical significance, and there were questions about the reliability of the study. Even the investigators in the trial said the results were insufficient by themselves to justify recommending use of the treatment.

Still, the unexpected finding should provide some vindication to the National Institutes of Health for sponsoring the $30 million study, which was plagued by delays and problems.

“There may be a biological effect and that biological effect should be taken seriously,” and “pursued with additional research,” Dr. Gervasio A. Lamas of Mount Sinai Medical Center in Miami, the lead investigator, said at a news conference here at the annual scientific meeting of the American Heart Association.

Dr. Elliott Antman, representing the heart association, applauded the National Institutes of Health for sponsoring the study while also expressing caution. “Intriguing as these results are, they are unexpected and should not be interpreted as an indication to adopt chelation therapy into clinical practice,” said Dr. Antman, a cardiologist at Brigham and Women’s Hospital in Boston.

Chelation therapy involves the infusion of agents that remove metals from the bloodstream.

More than 100,000 Americans with heart disease undergo chelation therapy each year, at a cost of about $5,000 per course of treatment, experts here said. The hypothesis is that chelation can remove the calcium that is a contributor to arterial plaques.

But skeptics said there was not enough evidence backing chelation therapy to even begin a clinical trial. Proponents of the study said that since chelation therapy was already widely used, it should be subject to the same rigorous scientific testing used to study conventional pharmaceuticals.

And some skeptics were not persuaded at all. Dr. Steven Nissen, head of cardiovascular medicine at the Cleveland Clinic, said the study was “fatally flawed,” with many of the doctors involved being on the fringes of medicine and many patients dropping out of the trial. He said if people got the mistaken idea from the study that chelation was beneficial “it would be a public health catastrophe.”

The study, which began enrolling patients in 2003, was plagued by problems from the start. It fell way behind its goal of recruiting nearly 2,400 patients in three years. The trial was also suspended in 2008 for investigations by government agencies, one over conduct at trial sites and the other about whether patients were being adequately informed that chelation can cause death. The study was allowed to resume the next year, after some changes were made.

The trial ended up with 1,708 patients at 134 centers in the United States and Canada. The patients all had had previous heart attacks.

Half the patients received the chelation therapy, a synthetic amino acid called disodium ethylene diamine tetra acetic acid, or EDTA, as well as other substances. These were given by infusion every week for 30 weeks, followed by 10 more infusions at intervals of two to eight weeks. The other half received infusions of placebo.

After a follow-up of 55 months, 26 percent of those who received chelation therapy had died, suffered a heart attack or stroke, had a procedure to reopen a coronary artery or had been hospitalized for angina. That was less than the 30 percent for those who received a placebo, a difference that was barely statistically significant.

Doctors said there were reasons for caution.

Virtually all the of difference between the treatment and the placebo groups occurred in the third of patients who had diabetes. The placebo contained some sugar, which conceivably could have harmed the diabetics. Also, at least within the first two years, the chelation therapy did not improve physical functioning or psychological well being, according to surveys of the patients.

Dr. Mark A. Creager, a cardiologist at Brigham and Women’s Hospital who was not involved in the study, said the chelation infusion also contained a high dose of vitamin C and the blood thinner heparin. It could be that one of those ingredients, not the chelation agent, were responsible for any benefit, he said.

Dr. Lamas, the lead investigator, said the chelation treatment was well tolerated. But he said investigators did not yet know why some patients receiving the therapy dropped out of the trial.

Another study presented at the heart meeting on Sunday found coronary bypass surgery superior to the use of stents for patients with diabetes and multiple heart blockages.

The trial involved 1,900 patients followed for five yeas. About 27 percent of those who received stents either died or had a heart attack or stroke, compared with about 19 percent of those undergoing bypass surgery. There was an increase in stroke risk with surgery, but that was outweighed by fewer deaths and heart attacks.

Previous studies had already suggested that surgery was better for diabetic patients with severe coronary disease, and practice guidelines already say it is “reasonable” to choose surgery. But the new study, sponsored by the National Institutes of Health, shows the same result even using modern drug-covered stents.

About 700,000 Americans undergo artery opening procedures for more than one blood vessel each year, and about 25 percent of them have diabetes, according to the investigators.

The study results were also published online by the New England Journal of Medicine. Johnson & Johnson and Boston Scientific provided the stents used in the study.

Read More..

Keeping 007 relevant in a changed world

NEW YORK — Early in "Skyfall," Judi Dench's M pulls aside our embattled hero, played once again with suave ennui by Daniel Craig, and wonders whether the world still needs either of their services. As Bond wraps his head around that idea, he looks searchingly at his boss. "So this is it?" he wonders. "We're both played out?"

Questions about relevance dangle throughout the new James Bond movie, which opens in the U.S., after a crescendo of marketing, on Nov 9. Field agents are of diminishing importance in an era of cyber-spying and drone warfare, and the uniqueness of Bond's gadgets has been diluted at a time when everyone and their great-aunt carries an iPhone.

PHOTOS: James Bond through the years

Yet as the film franchise turns 50 (yes, someone born the year "Dr. No" came out is now eligible to join AARP) themes of retirement and sell-by dates aren't simply screenplay fodder — they pertain to the franchise itself.

After strong early reviews and solid overseas business, the latest Bond adventure sweeps into theaters with blockbuster expectations. But even if the Sony release blows the doors off the box office like, well, 007 making a grand entrance, it can't hide what those who worked on it quietly acknowledge — making this movie was a more difficult and delicate undertaking than ever.

No longer is a successful Bond movie simply a matter of dialing up clever dialogue and dazzling set pieces. Facing a world that would be unrecognizable to those behind the early Ian Fleming adaptations, Bond filmmakers and actors grapple on many levels with how to keep the series fresh.

They must find ways for a tuxedo-wearing, martini-swilling protagonist to stay relatable while a global downturn rages. They need to project a contemporary degree of villainy in a world where the threat of Islamist terrorism is, for a variety of reasons, not as easily portrayed as the enemies and fears of the Cold War.

They want to retain at least a hint of gravitas after years of Austin Powers and Johnny English.

Maybe most important, they struggle with how to avoid what might be called the quaintness trap — staying relevant in a cinema culture that has seen the rise of splashy CG action movies on the one hand and modern truth-seekers a la Jason Bourne on the other.

"The theme of our story is that we have to question if the old classic things still work," said Javier Bardem, who plays the villain in "Skyfall," directed by Sam Mendes. "It's implied in every character in this movie. But it's also the question about the James Bond franchise."

New obstacles

For years, Barbara Broccoli, the longtime producer and steward of the spy series (total box office: about $5 billion), knew that she wanted a film for the franchise's 50th anniversary. "Bond 23," as "Skyfall" soon became known, was a way of honoring her late father, Albert "Cubby" Broccoli, who died in 1996 and was heavily responsible for putting Fleming's work on the screen. It also offered a third act in the Craig-led Bond.

About three years ago, with the blessing of studio MGM, Broccoli and stepbrother/fellow producer Michael Wilson hired the longtime Bond writers Neal Purvis and Robert Wade, along with "The Queen" scribe Peter Morgan. At nearly the same time they brought on Mendes, the British director of "American Beauty" who was in a slump after his young-marrieds drama "Away We Go" flopped in 2009.

Then MGM filed for bankruptcy, and suddenly everyone was frozen in place. (To avoid legal action from creditors, Mendes was retained off the books as a "consultant.")

PHOTOS: The Bond girls

"It was a nightmare," Broccoli recalled. "This was one of those situations that's really frustrating — when all the delays have nothing to do with the making of the movie." Craig's attitude was even more bleak. "I thought OK, we might have to say goodbye to this," he said in an interview in New York several weeks ago. "And that made me really sad." In the hiatus, Morgan left, replaced by the veteran John Logan ("Hugo").

MGM was finally reconstituted with new owners. But now came another problem: how to make Bond dramatically relevant again. The franchise wasn't just long in the tooth — it was coming off a disappointing entry in 2008's "Quantum of Solace." Craig acknowledged in the interview that the movie wasn't "satisfying." Wilson said that, after witnessing the critical reception, he thought, "Oh God, we really screwed this up."

A big reason for that was Bond's nemesis. During the decades that the series provided a catharsis for the Soviet threat, it was easy to put a face on the menace. But since the Iron Curtain fell — and especially after the attacks of Sept. 11 — that was a lot tougher.

In "Casino Royale," Craig's initiation, filmmakers used a clever work-around: They channeled the demons that would normally reside in the villain into the hero. Craig's Bond was grimmer and darker, which not only made for a compelling character but for some juicy zeitgeist stuff, Bond's beleaguered air matching our post-Sept. 11 anxiety.

In "Quantum," writers essentially opted out, creating villains and stakes that had little to do with the headlines (they involved a Bolivian coup and the arcana of water rights.) The film was rushed into production after the writers strike — "you shouldn't try to rewrite whole sections of the story while you're shooting," Craig noted dryly — and the results were wobbly.

Read More..

Head Hunter: Rare Specimens From a World-Class Skull Collection

If you were to go clicking down Alan Dudley’s anonymous-looking English street in Google’s Street View, there’d be no reason to stop outside his anonymous-looking English home. But inside, in a space no bigger than a child’s bedroom, Dudley has amassed one of the world’s most impressive private collections of skulls -- some 2,500 of them, incredibly well-organized and impeccably preserved. A good chunk of the animal kingdom is represented -- fish, reptiles, birds, and mammals fill the space.

British journalist Simon Winchester’s first reaction to the collection was horror. “I thought, ‘This is macabre, this is horrible, this is grotesque,’ because I was, I think like most of us, brought up to associate skulls with piracy or warning or danger or death,” Winchester says. “But then you see beneath the muscle and the skin something so beautiful, so finely constructed, that you can understand the fascination that someone like Dudley has. It may sound rather corny, but it gives you a new reverence for life.”

Winchester was so moved that he, along with an ex-BBC producer, created an app that showcased the collection. Though highly regarded when it launched last year, the app didn’t sell particularly well. But publishers in New York were interested in the material. When he was asked to turn the app into a book, Winchester happily agreed. The result is Skulls: An Exploration of Alan Dudley’s Curious Collection, which was published earlier this month. The book features hundreds of Dudley’s skulls, supplemented with rarer specimens and Winchester’s writings on skull lore and history. We spoke to Winchester about what he learned and the most interesting skulls he discovered. These are some of his favorites.

Above:

Winchester loves “the extraordinary canine teeth that look like horns but are actually teeth which curve back into its own head and make it look utterly weird.”

Read More..

DA seeks rehearing in Anna Nicole Smith drug case

LOS ANGELES (AP) — Prosecutors refusing to accept an appellate court‘s ruling in the Anna Nicole Smith case asked the court on Friday to change its decision and allow her former boyfriend and manager to be retried.

California’s 2nd District Court of Appeal ruled last month that Howard K. Stern could not be retried without violating the Fifth Amendment protection against double jeopardy. Attorneys in the office of District Attorney Steve Cooley filed a 19-page motion for rehearing that contends the court misinterpreted the law.

The court said a trial judge erred in dismissing conspiracy convictions against Stern and Smith’s psychiatrist, Dr. Khristine Eroshevich, in a case that partially revolved around obtaining prescription drugs for the celebrity model under false names. The defendants were not charged with causing her death.

Superior Court Judge Robert Perry found it was not unusual in the celebrity world Smith inhabited for fake names to be used to protect privacy. The appellate court sent the case back to Perry but gave no guidance on what the judge should do next.

The motion filed Friday asked that the court modify its ruling so that Stern can be retried, or to grant a rehearing on the issue.

The defendants’ nine-week trial was the final act of the long-running drama centering on the blond beauty’s troubled life, which was documented on reality TV, in tabloids and in trial testimony. The defendants were acquitted of most charges, and the judge suggested prosecutors had chosen the wrong case in which to make its point about prescription drug abuse.

Entertainment News Headlines – Yahoo! News

Read More..

Opinion: Seeing Things? Hearing Things? Many of Us Do

HALLUCINATIONS are very startling and frightening: you suddenly see, or hear or smell something — something that is not there. Your immediate, bewildered feeling is, what is going on? Where is this coming from? The hallucination is convincingly real, produced by the same neural pathways as actual perception, and yet no one else seems to see it. And then you are forced to the conclusion that something — something unprecedented — is happening in your own brain or mind. Are you going insane, getting dementia, having a stroke?

In other cultures, hallucinations have been regarded as gifts from the gods or the Muses, but in modern times they seem to carry an ominous significance in the public (and also the medical) mind, as portents of severe mental or neurological disorders. Having hallucinations is a fearful secret for many people — millions of people — never to be mentioned, hardly to be acknowledged to oneself, and yet far from uncommon. The vast majority are benign — and, indeed, in many circumstances, perfectly normal. Most of us have experienced them from time to time, during a fever or with the sensory monotony of a desert or empty road, or sometimes, seemingly, out of the blue.

Many of us, as we lie in bed with closed eyes, awaiting sleep, have so-called hypnagogic hallucinations — geometric patterns, or faces, sometimes landscapes. Such patterns or scenes may be almost too faint to notice, or they may be very elaborate, brilliantly colored and rapidly changing — people used to compare them to slide shows.

At the other end of sleep are hypnopompic hallucinations, seen with open eyes, upon first waking. These may be ordinary (an intensification of color perhaps, or someone calling your name) or terrifying (especially if combined with sleep paralysis) — a vast spider, a pterodactyl above the bed, poised to strike.

Hallucinations (of sight, sound, smell or other sensations) can be associated with migraine or seizures, with fever or delirium. In chronic disease hospitals, nursing homes, and I.C.U.’s, hallucinations are often a result of too many medications and interactions between them, compounded by illness, anxiety and unfamiliar surroundings.

But hallucinations can have a positive and comforting role, too — this is especially true with bereavement hallucinations, seeing the face or hearing the voice of one’s deceased spouse, siblings, parents or child — and may play an important part in the mourning process. Such bereavement hallucinations frequently occur in the first year or two of bereavement, when they are most “needed.”

Working in old-age homes for many years, I have been struck by how many elderly people with impaired hearing are prone to auditory and, even more commonly, musical hallucinations — involuntary music in their minds that seems so real that at first they may think it is a neighbor’s stereo.

People with impaired sight, similarly, may start to have strange, visual hallucinations, sometimes just of patterns but often more elaborate visions of complex scenes or ranks of people in exotic dress. Perhaps 20 percent of those losing their vision or hearing may have such hallucinations.

I was called in to see one patient, Rosalie, a blind lady in her 90s, when she started to have visual hallucinations; the staff psychiatrist was also summoned. Rosalie was concerned that she might be having a stroke or getting Alzheimer’s or reacting to some medication. But I was able to reassure her that nothing was amiss neurologically. I explained to her that if the visual parts of the brain are deprived of actual input, they are hungry for stimulation and may concoct images of their own. Rosalie was greatly relieved by this, and delighted to know that there was even a name for her condition: Charles Bonnet syndrome. “Tell the nurses,” she said, drawing herself up in her chair, “that I have Charles Bonnet syndrome!”

Rosalie asked me how many people had C.B.S., and I told her hundreds of thousands, perhaps, in the United States alone. I told her that many people were afraid to mention their hallucinations. I described a recent study of elderly blind patients in the Netherlands which found that only a quarter of people with C.B.S. mentioned it to their doctors — the others were too afraid or too ashamed. It is only when physicians gently inquire (often avoiding the word “hallucination”) that people feel free to admit seeing things that are not there — despite their blindness.

Rosalie was indignant at this, and said, “You must write about it — tell my story!” I do tell her story, at length, in my book on hallucinations, along with the stories of many others. Most of these people have been reluctant to admit to their hallucinations. Often, when they do, they are misdiagnosed or undiagnosed — told that it’s nothing, or that their condition has no explanation.

Misdiagnosis is especially common if people admit to “hearing voices.” In a famous 1973 study by the Stanford psychologist David Rosenhan, eight “pseudopatients” presented themselves at various hospitals across the country, saying that they “heard voices.” All behaved normally otherwise, but were nonetheless determined to be (and treated as) schizophrenic (apart from one, who was given the diagnosis of “manic-depressive psychosis”). In this and follow-up studies, Professor Rosenhan demonstrated convincingly that auditory hallucinations and schizophrenia were synonymous in the medical mind.

WHILE many people with schizophrenia do hear voices at certain times in their lives, the inverse is not true: most people who hear voices (as much as 10 percent of the population) are not mentally ill. For them, hearing voices is a normal mode of experience.

My patients tell me about their hallucinations because I am open to hearing about them, because they know me and trust that I can usually run down the cause of their hallucinations. For the most part, these experiences are unthreatening and, once accommodated, even mildly diverting.

David Stewart, a Charles Bonnet syndrome patient with whom I corresponded, writes of his hallucinations as being “altogether friendly,” and imagines his eyes saying: “Sorry to have let you down. We recognize that blindness is no fun, so we’ve organized this small syndrome, a sort of coda to your sighted life. It’s not much, but it’s the best we can manage.”

Mr. Stewart has been able to take his hallucinations in good humor, since he knows they are not a sign of mental decline or madness. For too many patients, though, the shame, the secrecy, the stigma, persists.

Oliver Sacks is a professor of neurology at the N.Y.U. School of Medicine and the author, most recently, of the forthcoming book “Hallucinations.”

Read More..